Donald Eagerton, MD
Basic profileDonald Eagerton is an Endocrinology/Metabolic physician affiliated with Strand Physician Specialists. OpenAlex indexes 16 publications with 2,816 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
64 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ModernaProgram year202574 paymentsResearch$795,869
- Eli LillyProgram year20255 paymentsResearch$277,116
- Boehringer IngelheimProgram year202558 paymentsResearch$60,212
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
32.5%Iron, parenteral preparations32.5%Ferric carboxymaltose100%Part B, office-administered≥13 patientsP2Y12 inhibitor0%Clopidogrel100%Part D<11 patientsMusculoskeletal
31.4%Other drugs affecting bone structure and mineralization22.8%Romosozumab-aqqg100%Part B, office-administered≥27 patientsRANK Ligand Inhibitor7.3%Denosumab100%Part B, office-administered≥59 patients+ 2 more classes in this area
Cardiovascular
25.5%Other lipid modifying agents22.2%Inclisiran100%Icosapent Ethyl0%Part D + Part B<11 patientsStatin1.7%Atorvastatin Calcium44%Rosuvastatin Calcium38%Pravastatin Sodium10%Simvastatin8%Part D≥121 patients+ 12 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes
JAMA Internal Medicine
2026 - SAT-784 The Role of Full Femur Imaging for Early Detection of Incomplete Atypical Femur Fractures
Journal of the Endocrine Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”